WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Pro Bono
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
De-Risking Growth: How Fractional Legal Advisory Services Drives Digital Health Success
Bylined Articles
October 22, 2025

From data privacy to regulatory compliance, embedded legal strategy is essential to building resilient, investor-ready businesses.

Digital health companies operate in one of the most complex and highly scrutinized industries. CEOs and founders are under constant pressure to scale quickly, differentiate in crowded markets, and navigate a maze of regulations. Investors, meanwhile, want confidence that companies have the right compliance and governance frameworks in place to support growth.

What many overlook is that legal is not just a cost center in this equation—it can be the strategic differentiator. By leveraging fractional advisory support, digital health companies can access senior-level expertise that turns legal complexity into a business advantage.

Understanding the Digital Health Landscape

Every digital health company faces a unique set of risks depending on who its customers are:

  • Provider-facing companies: Examples include EHR platforms, ambient listing scribes, patient engagement tools, and workflow automation. Their biggest hurdles often involve complex procurement cycles, technical integrations, and handling sensitive patient information.
  • Life sciences-facing companies: These companies help fuel drug discovery, development, and clinical trial operations through novel data platforms and AI. They must overcome strict regulatory scrutiny, high capital requirements, and fierce competition.
  • Payor-facing companies: These organizations support insurers and health plans with tools for utilization management, risk analytics, and value-based care. Success here means proving measurable outcomes (i.e., savings) while keeping costs down.

For each of these markets, the right legal partner provides not just risk management, but also frameworks that accelerate sales cycles, build trust with your soon-to-be clients, and support faster entry into partnerships.

Core Legal Competencies with a Strategic Lens

Providing effective legal advisory support to digital health companies means mastering a broad set of competencies while tailoring advice to the fundamental business objectives. This is where fractional advisors or embedded general counsel (GC) programs add value, by combining deep subject matter expertise with flexible engagement models.

  • Commercial agreements and risk allocation: Digital health companies negotiate SaaS agreements, data licenses, clinical trial collaborations, and joint development deals. A seasoned legal advisor can ensure clarity around IP ownership, data rights, indemnification, and liability caps while structuring contracts that shorten deal cycles and align with investor expectations.
  • Data privacy and use rights: HIPAA, GDPR, and CCPA compliance are table stakes. The real differentiator is building data use frameworks that enable monetization while protecting against re-identification risks. Experienced counsel can draft and negotiate these data rights in ways that unlock commercial value and reassure potential partners.
  • Regulatory compliance: From FDA oversight to state-by-state telehealth laws, regulatory uncertainty can stall growth. Leveraging on-demand senior counsel allows companies to get the right advice at the right time without bearing the cost of a full in-house regulatory team.
  • Corporate governance and strategic transactions: Investors increasingly expect “investor-ready” governance. Fractional advisors and GC-in-Residence models help companies put scalable controls in place, so they’re prepared for financings, M&A, or regulatory scrutiny well before these events occur.
  • Employment and equity: Mission-driven teams need tailored guidance on compensation, equity, restrictive covenants, and remote workforce policies. Advisory models can help align culture and compliance with long-term value creation at a fraction of the cost of building out a full HR legal function.

Legal as a Growth Partner

The most successful digital health companies do not see legal as a back-office function. They embed legal as part of the executive team, shaping product, sales, finance, and operations decisions. Through this tactical approach, legal not only supports, but actively contributes to, the strategic direction of the company, resulting in several key benefits:

  • Risk management becomes proactive rather than reactive, protecting patient safety and brand reputation.
  • Data strategies are aligned with both compliance and commercialization opportunities.
  • Negotiations with customers, regulators, and auditors are handled by advisors who understand the sector inside and out.

This is where fractional and embedded advisory models add unique value. They combine cross-company experience from dozens of digital health businesses with the flexibility to scale support as the company grows. Rather than treating legal as reactive outside counsel, these models integrate directly with leadership teams, aligning legal strategy with commercial outcomes.

Call to Action

For CEOs, founders, and investors in digital health, the question is not whether you need legal support—it’s whether you have the right kind of support. The stakes are too high to rely on generic counsel and too dynamic to justify a full-time hire in the earliest stages.

If you are scaling a digital health company—or investing in one—now is the time to secure the right kind of legal support. Through fractional advisory services and Wilson Sonsini’s General Counsel in Residence program, companies gain:

  • Advanced expertise in digital health without the cost of a full-time GC.
  • Flexible pricing models aligned with company stage and budget.
  • Faster deal execution with customers, partners, and investors.
  • Investor-ready governance and compliance frameworks.
  • A trusted partner who can translate legal complexity into operational clarity.

If this resonates, reach out to explore how tailored legal advisory support can help position your business for scale and long-term success by contacting Marc Berger or visiting http://www.wsgr.com.

  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.